Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
CholecystitisCholelithiasisBiliary Dyskinesia
Interventions
DEVICE

ICG

"Patient will receive a standard dose of indocyanine green (ICG) 45 minutes prior to surgery. ActivSight will be used during laparoscopic cholecystectomy - the surgeon will perform the procedure in their standard fashion.~Video data will be analyzed in real-time by Activ Surgical's ActivInsight surgical artificial intelligence platform to identify anatomic structures and surgical phase. The surgeon will be blinded to this information, and will see the standard screens and information they do when performing the procedure in a non-study setting."

Trial Locations (1)

77030

RECRUITING

Memorial Hermann Texas Medical Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Activ Surgical

INDUSTRY